| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|
Cooke, Graham S
|
|
2019
|
4 |
2 |
p. 135-184
|
artikel
|
| 2 |
Accelerating the elimination of viral hepatitis for Indigenous peoples
|
Cunningham, Chris
|
|
2019
|
4 |
2 |
p. 93-94
|
artikel
|
| 3 |
Civil society's critical role in the elimination of viral hepatitis
|
Peck, Raquel
|
|
2019
|
4 |
2 |
p. 90-91
|
artikel
|
| 4 |
Correction to Lancet Gastroenterol Hepatol 2018; 3: 825–36
|
|
|
2019
|
4 |
2 |
p. e1
|
artikel
|
| 5 |
Diagnostic accuracy of MRE and ultrasound for Crohn's disease
|
Novak, Kerri
|
|
2019
|
4 |
2 |
p. 95-96
|
artikel
|
| 6 |
Diagnostic accuracy of MRE and ultrasound for Crohn's disease – Authors' reply
|
Taylor, Stuart A
|
|
2019
|
4 |
2 |
p. 96
|
artikel
|
| 7 |
Direct-acting antiviral therapy in sub-Saharan Africa
|
Spearman, C Wendy
|
|
2019
|
4 |
2 |
p. 85-86
|
artikel
|
| 8 |
Effective drugs on the road to HCV elimination and a therapeutic gap to close
|
Muljono, David H
|
|
2019
|
4 |
2 |
p. 86-88
|
artikel
|
| 9 |
Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial
|
Miller, Eric A
|
|
2019
|
4 |
2 |
p. 101-110
|
artikel
|
| 10 |
Elimination of viral hepatitis by 2030: ambitious, but achievable
|
Brierley, Rob
|
|
2019
|
4 |
2 |
p. 88-89
|
artikel
|
| 11 |
Faecal immunochemical tests: when quantitation is not enough
|
Halloran, Stephen P
|
|
2019
|
4 |
2 |
p. 83-84
|
artikel
|
| 12 |
Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme
|
de Klerk, Clasine M
|
|
2019
|
4 |
2 |
p. 111-118
|
artikel
|
| 13 |
Probiotics: elixir or empty promise?
|
The Lancet Gastroenterology & Hepatology,
|
|
2019
|
4 |
2 |
p. 81
|
artikel
|
| 14 |
Project ECHO: democratising knowledge for the elimination of viral hepatitis
|
Arora, Sanjeev
|
|
2019
|
4 |
2 |
p. 91-93
|
artikel
|
| 15 |
Research in brief
|
Baker, Holly
|
|
2019
|
4 |
2 |
p. 99
|
artikel
|
| 16 |
Samuel Gee: the modern era for coeliac disease
|
Burki, Talha Khan
|
|
2019
|
4 |
2 |
p. 100
|
artikel
|
| 17 |
Sigmoidoscopy: a shortcut to effective screening or a dead end?
|
Bugajski, Marek
|
|
2019
|
4 |
2 |
p. 82-83
|
artikel
|
| 18 |
Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial
|
Wei, Lai
|
|
2019
|
4 |
2 |
p. 127-134
|
artikel
|
| 19 |
The Liver Meeting 2018
|
Van Epps, Heather
|
|
2019
|
4 |
2 |
p. 98
|
artikel
|
| 20 |
Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir–sofosbuvir (SHARED): a single-arm trial
|
Gupta, Neil
|
|
2019
|
4 |
2 |
p. 119-126
|
artikel
|
| 21 |
Watch-and-wait strategy in rectal cancer
|
Bujko, Krzysztof
|
|
2019
|
4 |
2 |
p. 96-97
|
artikel
|
| 22 |
Watch-and-wait strategy in rectal cancer – Authors' reply
|
Chadi, Sami A
|
|
2019
|
4 |
2 |
p. 97
|
artikel
|
Tijdschrift beschrijving